FDA Commissioner Marty Makary defended thousands of staff cuts during his first congressional hearing since taking office, ...

Hinge Health shares jumped 23% in its first day trading as a public company, setting the tone for digital health after a ...

Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...

The White House released its first MAHA Commission report, detailing some of the Trump administration’s top priorities for ...

First sale rule allows pharma companies to reduce tariff duties by declaring lower drug values at US customs, as industry ...

Endpoints News announces URL change from endpts.com to endpoints.news effective June 1, 2025, with legacy redirects planned ...

Venrock's Healthcare Prognosis survey shows 71% favor AI integration in existing companies over new AI firms, with mixed ...

Beam Therapeutics CEO John Evans warns against AI hype in drug development, drawing parallels to past CRISPR expectations, ...

Sanofi will acquire Vigil for its oral small molecule TREM2 project, dubbed VG-3927, that is on tap for a Phase 2 in ...

Hinge Health prices IPO at $32/share, valuing company at $3B. CEO Daniel Perez's firm to trade as HNGE on NYSE, raising ...

FDA requests Moderna, Pfizer/BioNTech add safety warnings about myocarditis risk to COVID-19 vaccines, with specific rates ...

The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.